Medspa Equipment and Startup Financing in Washington, DC

Scan the situations below, find the one that matches where you are right now, and follow the link — each guide goes deep on that specific path so you can act without wading through options that don't apply to you.

What to know before you choose a financing path

Aesthetic medicine in Washington, DC runs on capital-intensive equipment. A single diode or Nd:YAG laser can run $80,000–$200,000; a full injectable inventory refresh for a busy practice can consume $30,000–$60,000 in a quarter. The financing structure you choose affects monthly cash flow, tax treatment, and how quickly you can upgrade when the next device generation arrives — so the decision is worth a few minutes of orientation.

The four paths most DC aesthetics practitioners actually use:

• Equipment financing (loan) — The device serves as its own collateral, which is why lenders move fast: approvals typically land in 1–3 days. Rates for borrowers with a 700+ FICO run 7–11% APR; fair-credit borrowers (620–679) pay 2–4 points more. Down payments are usually 10–20%, rising to 20–30% if your score is below 620. You own the asset, can claim Section 179 (up to $1,220,000 in 2026), and keep any residual value.
• Equipment leasing — Lower monthly payments, no large down payment, and a clean upgrade path at lease-end. The trade-off: you build no equity and lose the depreciation deduction. Best fit for practitioners who rotate devices frequently or want to preserve credit lines for other uses.
• SBA 7(a) loan — The right tool for larger startup packages — buildout, equipment, and working capital in one loan up to $5,000,000. Rates run 8.5–11% APR in 2026, terms up to 10 years for equipment. The cost is time: SBA approval takes 30–45 days, and you need at least 24 months in business (or a strong business plan if pre-revenue). Minimum credit score is 640+.
• Working capital / lines of credit — Injectable inventory, staff payroll between busy seasons, and marketing spend are better served by a revolving line or short-term working capital loan (8.5–11% APR for qualified borrowers) than by an equipment loan. Merchant cash advances are available with weaker credit but carry APR equivalents of 25–80%+; use them only when speed is critical and other doors are closed.

What trips practitioners up most often:

• Mixing capital types — Financing a $150,000 laser on a working capital line means paying short-term rates on a long-lived asset. Match loan term to asset life.
• Ignoring the debt service math — Lenders want your total monthly debt payments to stay below 45–50% of revenue, and a DSCR of at least 1.25x. Run those numbers before you apply so you know how much room you have.
• Underestimating documentation — Most lenders review 12 months of bank statements. Have them organized before you start shopping.
• Skipping the tax conversation — The Section 179 deduction can dramatically change the after-tax cost of buying versus leasing. A conversation with your accountant before closing is not optional.

DC practitioners financing injectable inventory alongside equipment should know that supply chain financing for aesthetic injectables is its own product category, with different approval criteria and advance rates than standard equipment loans — it's worth comparing structures rather than defaulting to whatever your equipment lender offers.

Practitioners in other markets exploring similar decisions — including those looking at medspa equipment financing in Anaheim, CA or options available to providers in Anchorage, AK — will find that while lender availability varies by market, the core qualification math (DSCR, FICO thresholds, down payment requirements) is consistent across most of the country.

Orientation done — use the guides linked below to match your situation and move forward.